PuSH - Publication Server of Helmholtz Zentrum München

Beyerlein, A. ; Jolink, M.

Evaluation of the Fr1da screening: From an epidemiological perspective.

Evaluation of the Fr1da-screening from an epidemiological perspective.

Diabetologie 14, 221-223 (2018)
Postprint DOI
Open Access Green
Background: In the Fr1da study (“Typ 1 Diabetes: Früh erkennen – Früh gut behandeln”), children between 2 and 5 years of age are screened for presymptomatic type 1 diabetes in Bavaria, Germany. Objectives: Here, we show preliminary results on the success and acceptance of the Fr1da screening. Materials and methods: Participation rates, analytic quality, as well as the well-being and the ketoacidosis rates in families with presymptomatic type 1 diabetes were considered as main criteria. Results: Between 2015 and 2017, 72,459 children participated in the Fr1da screening. None of the 223 children (0.3%) diagnosed with presymptomatic type 1 diabetes have had a ketoacidosis event. In 95% of the affected families, no or only mild depressive symptoms were reported after diagnosis. Conclusions: The acceptance of the Fr1da screening among the participating physicians and families is high. It is particularly encouraging that no ketoacidosis has been reported yet in any of the children with early type 1 diabetes.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Review
Corresponding Author
Keywords Autoantibodies ; Child ; Diabetes Mellitus, Type 1 ; Early Diagnosis ; Ketoacidosis; Cell-line Thp-1; In-vitro; Hacat Keratinocytes; Alkaloid Berberine; Dendritic Cells; Injury; Skin; Sensitization; Expression; Toxicity
ISSN (print) / ISBN 2731-7447
e-ISSN 2731-7455
Journal Diabetologie, Die
Quellenangaben Volume: 14, Issue: 4, Pages: 221-223 Article Number: , Supplement: ,
Publisher Springer
Publishing Place Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research Type 1 (IDF)